(Q35725065)

9 August 2017

1 reference

title

Gut microorganisms as promising targets for the management of type 2 diabetes (English)

1 reference

9 August 2017

1 reference

2

1 reference

9 August 2017

Audrey M Neyrinck

4

0 references

Nathalie M. Delzenne

object named as

Nathalie M Delzenne

series ordinal

1

0 references

Laure B Bindels

series ordinal

5

object named as

Laure B Bindels

1 reference

9 August 2017

3

Amandine Everard

1 reference

9 August 2017

31 July 2015

1 reference

9 August 2017

1 reference

9 August 2017

58

1 reference

9 August 2017

10

1 reference

9 August 2017

2206-2217

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-015-3712-7

9 August 2017

0 references

cites work

Human genetics shape the gut microbiome.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

A metagenome-wide association study of gut microbiota in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Gut metagenome in European women with normal, impaired and diabetic glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Higher blood glucose level associated with body mass index and gut microbiota in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Richness of human gut microbiome correlates with metabolic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Inflammatory mechanisms in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Inferences, questions and possibilities in Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

A nonsense polymorphism (R392X) in TLR5 protects from obesity but predisposes to diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Phylogenetic distribution of three pathways for propionate production within the human gut microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

G-protein-coupled receptors in intestinal chemosensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Luminal glucagon-like peptide-1(7-36) amide-releasing factors in the isolated vascularly perfused rat colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

GPR43/FFA2: physiopathological relevance and therapeutic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Gut microbiota and GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

TGR5-mediated bile acid sensing controls glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Bile acid metabolism and the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC-ε pathway and modulated by endogenous H2S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Changes in bile acids, FGF-19 and sterol absorption in response to bile salt hydrolase active L. reuteri NCIMB 30242.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Molecular mechanism of action of metformin: old or new insights?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Effect of metformin on metabolic improvement and gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Sitagliptin reduces hyperglycemia and increases satiety hormone secretion more effectively when used with a novel polysaccharide in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

The importance of the gut microbiota after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

FXR is a molecular target for the effects of vertical sleeve gastrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Lactobacillus gasseri SBT2055 reduces postprandial and fasting serum non-esterified fatty acid levels in Japanese hypertriacylglycerolemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Mycobiota in gastrointestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Human gut microbiota in obesity and after gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Age, dietary fiber, breath methane, and fecal short chain fatty acids are interrelated in Archaea-positive humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Commensal-pathogen interactions in the intestinal tract: lactobacilli promote infection with, and are promoted by, helminth parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Food-based ingredients to modulate blood glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Towards a more comprehensive concept for prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Impact of inulin and oligofructose on gastrointestinal peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Can dietary fructans lower serum glucose?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Contents of dietary fibre components and their relation to associated bioactive components in whole grain wheat samples from the HEALTHGRAIN diversity screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Comparison of prebiotic effects of arabinoxylan oligosaccharides and inulin in a simulator of the human intestinal microbial ecosystem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Evaluation of the prebiotic properties of wheat arabinoxylan fractions and induction of hydrolase activity in gut microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Green tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Concentrated arabinoxylan but not concentrated β-glucan in wheat bread has similar effects on postprandial insulin as whole-grain rye in porto-arterial catheterized pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Concentrated arabinoxylan in wheat bread has beneficial effects as rye breads on glucose and changes in gene expressions in insulin-sensitive tissues of Zucker diabetic fatty (ZDF) rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Arabinoxylan fibre improves metabolic control in people with Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Arabinoxylan fibre consumption improved glucose metabolism, but did not affect serum adipokines in subjects with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Arabinoxylan-enriched meal increases serum ghrelin levels in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Postprandial effects of test meals including concentrated arabinoxylan and whole grain rye in subjects with the metabolic syndrome: a randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3712-7

Influence of cross-linked arabinoxylans on the postprandial blood glucose response in rats

21 January 2018

1 reference

12 December 2020

Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms

1 reference

12 December 2020

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

1 reference

12 December 2020

Artificial sweeteners induce glucose intolerance by altering the gut microbiota

1 reference

12 December 2020

Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats

1 reference

12 December 2020

Intestinal methane production in obese individuals is associated with a higher body mass index

1 reference

12 December 2020

Tryptophanase in Diverse Bacterial Species

1 reference

12 December 2020

Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents

1 reference

12 December 2020

Health: The weighty costs of non-caloric sweeteners

1 reference

12 December 2020

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity.

1 reference

12 December 2020

Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal

1 reference

12 December 2020

Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity

1 reference

12 December 2020

Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition

1 reference

12 December 2020

Arabinoxylan fiber from a by-product of wheat flour processing behaves physiologically like a soluble, fermentable fiber in the large bowel of rats

1 reference

12 December 2020

In Vitro Fermentation by Human Fecal Microflora of Wheat Arabinoxylans

1 reference

12 December 2020

Combining sitagliptin/metformin with a functional fiber delays diabetes progression in Zucker rats

1 reference

12 December 2020

Digestive and physiologic effects of a wheat bran extract, arabino-xylan-oligosaccharide, in breakfast cereal

1 reference

12 December 2020

The effects of a diet rich in inulin or wheat fibre on markers of cardiovascular disease in overweight male subjects

1 reference

12 December 2020

Microbial metabolites of tryptophan in the intestinal tract with special reference to skatole,

1 reference

12 December 2020

Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control

1 reference

12 December 2020

Acarbose treatment affects the serum levels of inflammatory cytokines and the gut content of bifidobacteria in Chinese patients with type 2 diabetes mellitus

1 reference

12 December 2020

Human gut microbiota changes reveal the progression of glucose intolerance

1 reference

12 December 2020

10.1007/S00125-015-3712-7

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

26224102